TaeWoong Medical USA

What TaeWoong Medical USA does

TaeWoong Medical USA is the exclusive US distribution subsidiary of Taewoong Medical Co., Ltd., a South Korean minimally invasive medical device manufacturer founded in 1991. The company distributes a portfolio of gastrointestinal devices to US hospitals, gastroenterologists, and advanced endoscopists, organized into three core lines: self-expanding metallic stents under the Niti-S brand (esophageal, biliary, colonic, duodenal, and through-the-scope variants); endoscopic radiofrequency ablation systems (EUSRA for EUS-guided ablation, ELRA for endobiliary ablation, and the VIVA Combo RF generator); and accessories including the EndoDrill GI electric-driven EUS core needle biopsy device, ClearTip FNA/FNB/Franseen needles, cystotomes, guidewires, and snares. Its proprietary technology is grounded in nitinol-based stent design, with the company claiming pioneering TTS (through-the-scope) esophageal stent placement in the US and sole-market status for an FDA-cleared RFA electrode designed for EUS use.

The company generates revenue through hardware sales of medical devices to hospitals and GI centers, using an enterprise field sales motion supplemented by clinical specialist support, conference participation at Digestive Disease Week (DDW), and structured training programs (TaeWoong Academy and TaeWoong StentLab). Pricing is not publicly disclosed and is understood to be negotiated at the facility level. Its US operating footprint consists of sales and marketing offices in Los Angeles, California, while manufacturing and R&D remain centralized at the parent's Gimpo-si, South Korea facility. Recent regulatory and clinical milestones include FDA 510(k) clearance for the SPAXUS stent in 2026 with a reported 97.1% clinical success rate in pancreatic pseudocyst drainage.

TaeWoong Medical USA's distribution model has expanded materially in 2025 through two core partnerships: an exclusive US distribution agreement with BiBBInstruments AB for EndoDrill GI (May 2025, with US launch in October 2025 and planned nationwide rollout in 2026), and an exclusive partnership with Mauna Kea Technologies to integrate Cellvizio optical biopsy into its EUS-guided pancreatic cyst management workflow (December 2025). The company positions itself within a broader global network reaching 79 countries and over 1.2 million procedures performed using TaeWoong devices. VetSarang, a dedicated veterinary sub-brand for companion animal stenting, extends the platform beyond human GI into a secondary vertical.

Name

TaeWoong Medical USA

Legal name

TaeWoong Medical USA

Website

https://taewoongusa.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

TaeWoong Medical USA is the exclusive US distributor of Taewoong Medical Co., Ltd.'s minimally invasive gastrointestinal medical devices — including nitinol stents, RFA systems, and EUS biopsy tools — serving gastroenterologists, advanced endoscopists, and hospitals across the United States.

Ownership category

akta.pro rank

Headquarters

HQ city

Kimpo

HQ country

South Korea

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Medical Device Distribution: Distribution of gastrointestinal medical devices including stents, RFA systems, and accessories to hospitals and healthcare professionals in the United States. Revenue is generated through product sales to healthcare facilities.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

TaeWoong Medical USA distributes and sells a portfolio of gastrointestinal medical devices in the United States, including the Niti-S family of self-expanding metallic stents (biliary, esophageal, colonic, duodenal, and through-the-scope variants), EUS-guided and endobiliary radiofrequency ablation systems (EUSRA, ELRA, VIVA Combo generator), and accessories such as the EndoDrill GI biopsy device, ClearTip needles, guidewires, snares, and cystotomes. The company also offers the VetSarang veterinary line and the TaeWoong StentLab hands-on training program.

Product overview

TaeWoong Medical USA is a distributor of gastrointestinal medical devices, offering a comprehensive portfolio organized into three main product categories. The core product line includes Niti-S™ branded self-expanding metallic stents (biliary, esophageal, colonic, duodenal, and through-the-scope variants) and endoscopic RFA systems (EUSRA™ for EUS-guided ablation, ELRA™ for endobiliary ablation, and VIVA Combo RF Generator). GI accessories include EndoDrill® GI (electric-driven EUS biopsy device), ClearTip needles, Cystotome, Guidewire, and Snare products. The company also offers TaeWoong StentLab™ training services and VetSarang veterinary products. The portfolio is designed to support minimally invasive GI procedures across diagnostic, therapeutic, and palliative care applications.

Differentiator

Problem solved

Functional benefit

Brands

• VetSarang: Dedicated veterinary products brand for companion animals, including gastrointestinal stents, accessories, and urology stents.
• Niti-S

Products and services

• Niti-S SPAXUS Stent A fully covered, self-expanding metallic stent with a bi-flange design for EUS-guided transluminal drainage. Indicated for pancreatic pseudocyst, walled-off necrosis, and gallbladder drainage in high-risk surgical patients.
• Niti-S Biliary Stent Uncovered biliary stent with unfixed cell design offering minimal foreshortening and accurate positioning. Indicated for malignant biliary strictures.
• Niti-S Esophageal Stent Single woven nitinol esophageal stent available in diameters 16-20mm with lengths up to 15cm and large flanges up to 28mm. Features silicone covering and soft round crowns to reduce tissue ingrowth.
• Niti-S Colonic and Duodenal Comfort Stents Flexible nitinol self-expanding stents for natural conformity in the colon and duodenum, with body sizes of 22-24mm and flange sizes up to 29mm.
• Niti-S Biliary Slim M Stent 6Fr delivery biliary stent with ultra-tapered tip, handwoven hook and cross construction, radiopaque markers, and stent lengths up to 12cm.
• Esophageal TTS Stent Through-the-scope esophageal stent with 10.5Fr catheter allowing placement in tight strictures. Available in diameters 18mm, 20mm, and 22mm with 'one to one' deployment system. Only company offering these diameters of TTS stents in the US.
• EUSRA EUS-Guided RFA System 19G RFA needle for EUS-guided ablation of soft tissue lesions and pancreatic tumors. The only RFA electrode available in the US designed for EUS use. Available in 5mm, 7mm, or 10mm tip lengths with water cooling system.
• ELRA Endobiliary RFA Electrode Bipolar RFA electrode for tissue ablation in the biliary tract. Available in multiple sizes (11mm, 18mm, 22mm, 33mm) with 7FR catheter and conical tip. Combined with VIVA Combo generator for real-time impedance and temperature control.
• VIVA Combo RF Generator System Radiofrequency ablation generator operating at 5-200 Watts, suitable for tumors in thyroid, parathyroid, biliary, pancreatic, liver, lung, kidney, uterine fibroid and bone. Features Continuance Mode and Temperature Mode with automatic power shutoff.
• EndoDrill GI World's first US FDA-cleared and EU CE-approved electric-driven core needle biopsy device for EUS-guided tissue sampling. Features motorized rotating drill-tip cylinder for deep, precise tissue sampling in submucosal and extramural GI lesions.
• ClearTip Needle Family EUS biopsy needle family with push-button locking for one-handed adjustment. Available in FNA (back-cut bevel), FNB (bidirectional blade), and Franseen types in 19G, 22G, 25G gauges with spiral echo design for ultrasound visibility.
• Cystotome Electrosurgical accessory for cannulating the transgastric or transduodenal wall into pancreatic pseudocysts. Available in 6Fr, 7Fr, and 8.5Fr sizes, accommodating guidewire up to 0.035'. Supplied sterile for single use.
• Guidewire Double-layer hydrophilic coated guidewire for low friction navigation and smooth device exchange. Features flexible polyurethane tip to reduce perforation risk. Available in straight and angled configurations.
• Snare Dual-stage cold snare for controlled polypectomy. FYC model offers adjustable 10mm and 20mm loop diameters with rotatable loop technology for precise orientation during procedures.
• VetSarang Veterinary Devices Dedicated product line for companion animals, including the VetSarang D Stent for intraluminal stenting, primarily for treatment of tracheal collapse. Provides less invasive interventional devices for veterinary medicine.
• TaeWoong StentLab Training Program In-suite, hands-on training program for GI physicians and fellows. Mobile training delivered in endoscopy suites for practice with TaeWoong's full range of self-expanding metal stents.

Quantifiable outcome

• 97.1% clinical success rate in treating pancreatic pseudocysts with SPAXUS stent
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• Mauna Kea TechnologiescoreStrategic or Co-development Partner · 3 December 2025Exclusive partnership to integrate Cellvizio into TaeWoong's EUS-guided therapeutic device portfolio in the US, creating a comprehensive pancreatic cyst management solution. Aims to streamline workflow, improve diagnostic accuracy, and enhance patient care for pancreatic conditions. Expected to expand clinical adoption of Cellvizio and set a new standard in EUS-guided pancreatic care.
• BiBBInstruments ABcoreChannel Partner/ Reseller/ Distributor · 2 May 2025TaeWoong Medical USA serves as the exclusive US distribution partner for BiBBInstruments' EndoDrill GI - the world's first FDA-cleared and EU CE-approved electric-driven core needle biopsy device for EUS-CNB. Partnership aims to accelerate US launch of EndoDrill GI, with targeted launch in select US hospitals in Fall 2025 followed by nationwide rollout in 2026. Joint customer demonstrations conducted at DDW 2025.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Boston Scientific: Boston Scientific is a direct competitor in GI stenting (WallFlex family) and EUS accessories, with overlapping endoscopic product lines and a substantially larger US sales force serving the same gastroenterology customers as TaeWoong.
• Cook Medical: Cook Medical directly competes in GI endoscopy with stents, FNA/FNB needles (EchoTip), and accessories, and shares the same enterprise field-sales motion targeting hospitals and gastroenterologists.
• Merit Medical: Merit Medical offers an overlapping portfolio of GI and esophageal stents (AlimaXX family) sold through hospital sales channels, making it a comparable specialty medical device peer in the same clinical indications.
• Micro-Tech Endoscopy: Micro-Tech Endoscopy sells GI biopsy needles, stents, and accessories, directly competing with TaeWoong's ClearTip and stenting lines through similar hospital-channel sales to gastroenterologists.
• Hobbs Medical: Hobbs Medical is a specialty manufacturer of GI stents and accessories with a comparable focus on therapeutic endoscopy devices sold to hospitals, directly overlapping with TaeWoong's stent portfolio.
• CONMED: CONMED competes in GI endoscopy with biopsy tools, electrosurgical accessories, and related devices sold into the same gastroenterology and hospital channels as TaeWoong's accessories portfolio.

Broad incumbents

• Medtronic: Medtronic offers a broad GI and endoscopy portfolio including EUS-FNB needles (Beacon) and GI devices, competing with TaeWoong across multiple product lines through a much larger US sales organization.
• Olympus Medical: Olympus is the dominant endoscopy system vendor and serves the same gastroenterology customer base, with adjacent and overlapping capabilities in therapeutic endoscopy devices and consumables.
• Pentax Medical (HOYA): Pentax Medical supplies endoscopy systems and a range of GI accessories to gastroenterologists, overlapping with TaeWoong's customer base and competing in adjacent device categories.
• Fujifilm Healthcare: Fujifilm's healthcare division sells endoscopy systems and GI accessories to the same advanced endoscopy customer segment, making it a broad incumbent peer competing for hospital budgets and procedure volume.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/taewoongmedical
• LinkedInlinkedin.com/company/taewoong-medical-usa

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TaeWoong Medical USA